Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

VNDA Stock Annual Cash Flow. Download in Excel

Vanda Pharmaceuticals Inc. logo

Vanda Pharmaceuticals Inc.

Sector: Healthcare   

Industry: Biotechnology

4.94
 
USD
  
0.04
  
(0.82%)
Previous close: 4.9  Open: 4.91  Bid: 4.94  Ask: 4.99
52 week range    
3.46   
   6.75
Mkt Cap: 287 M  Avg Vol (90 Days): 620,252
Peers   
NVS / 
LLY / 
JNJ / 
BMY / 
PFE / 
TTNP / 
Last updated: Friday 22nd November 2024

Stock Rankings

44
MarketXLS Rank
60
Value
38
Technical
34
Quality
How are these ranks calculated?
Ad slot not ready
Search for a stock

Financials

VNDA Cash Flow

Annual
Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
(Increase) Decrease in inventories-2 M387000.0200000.0-1 M70000.0-722000.0-3 M-2 M-4 M-771000.0
(Increase) Decrease in other current assets-28000.0
(Increase) Decrease in other current liabilities-30 M
(Increase) Decrease in other working capital-78 M
(Increase) Decrease in payables1 M9 M575000.06 M-618000.04 M4 M3 M12 M-11 M
(Increase) Decrease in receivables-2 M-13 M-4 M3 M-11 M2 M-4 M-2 M-1 M-707000.0
Amortization of intangibles2 M13 M11 M2 M2 M2 M1 M1 M2 M2 M
CapitalExpenditureReported9 M3 M1 M2 M25 M1 M2 M552000.0679000.0383000.0
Cash at beginning of period65 M61 M51 M41 M34 M62 M46 M62 M53 M135 M
Cash at end of period61 M51 M40 M34 M62 M46 M62 M53 M135 M136 M
Cash flow-79 M17 M-8 M-2 M30 M46 M52 M64 M32 M13 M
CashFlowFromContinuingInvestingActivities-12 M-27 M-10 M-10 M-110 M-68 M-41 M-77 M50 M-12 M
ChangeInAccountPayable1 M9 M575000.06 M-618000.04 M4 M3 M12 M-11 M
ChangeInAccruedExpense1 M
ChangeInInterestPayable1 M
ChangeInPayablesAndAccruedExpense1 M9 M575000.06 M-618000.04 M4 M3 M12 M-11 M
ChangeInPrepaidAssets-318000.0-3 M-6 M4 M-4 M-3 M4 M-1 M-6 M9 M
ChangeInWorkingCapital-81 M-5 M-10 M11 M-16 M2 M1 M-3 M89000.0-4 M
ChangesInAccountReceivables-2 M-13 M-4 M3 M-11 M2 M-4 M-2 M-1 M-707000.0
Current deferred income taxes-104000.0-88 M6 M7 M1 M-1 M
Deferred income taxes-104000.0-88 M6 M7 M1 M-1 M
Depreciation530000.0582000.0935000.01 M1 M1 M1 M1 M1 M900000.0
Depreciation unreconciled3 M14 M12 M3 M3 M3 M3 M3 M3 M3 M
DepreciationAndAmortization3 M14 M12 M3 M3 M3 M3 M3 M3 M3 M
Effect of exchange rate changes6000.042000.0-38000.0-1000.053000.0-91000.0265000.047000.0
FinancingCashFlow90 M-283000.08 M5 M107 M6 M6 M4 M734000.0
Free cash flow-90 M14 M-10 M-4 M5 M45 M50 M64 M31 M12 M
GainLossOnInvestmentSecurities-3 M-50000.02 M-3 M-8 M
Issuance of capital stock62 M101 M
IssuanceOfCapitalStock62 M101 M
Net cash from financing activities62 M-283000.08 M5 M107 M6 M6 M4 M700000.0
Net cash from investing activities-12 M-27 M-10 M-10 M-110 M-68 M-41 M-77 M50 M-12 M
Net cash from operating activities-82 M17 M-8 M-2 M30 M46 M52 M64 M32 M13 M
Net change in cash & cash equivalents-4 M-10 M-10 M-7 M27 M-16 M16 M-9 M83 M745000.0
Net income from continuing operations20 M-40 M-18 M-16 M25 M116 M23 M33 M6 M3 M
NetCommonStockIssuance62 M101 M
NetIntangiblesPurchaseAndSale-8 M-25 M
NetInvestmentPropertiesPurchaseAndSale-3 M-24 M-9 M-9 M-84 M-67 M-40 M-76 M51 M-12 M
NetInvestmentPurchaseAndSale-3 M-24 M-9 M-9 M-84 M-67 M-40 M-76 M51 M-12 M
NetPPEPurchaseAndSale-769000.0-3 M-1 M-2 M-368000.0-1 M-2 M-552000.0-679000.0-383000.0
Operating (gains) losses-3 M-50000.02 M-3 M-8 M
Other financing charges net-436000.0-283000.0
Other investing changes net245000.0-46000.0124000.0-101 M
Other non-cash items-21 M49 M8 M-470000.018 M16 M18 M23 M25 M21 M
ProceedsFromStockOptionExercised8 M5 M6 M6 M6 M4 M700000.0
Purchase of Float term investments-93 M-193 M-165 M-148 M-282 M-395 M-347 M-420 M-349 M-513 M
Purchase of property plant & equipment-9 M-3 M-1 M-2 M-25 M-1 M-2 M-552000.0-679000.0-383000.0
PurchaseOfIntangibles-8 M-25 M
PurchaseOfInvestment-93 M-193 M-165 M-148 M-282 M-395 M-347 M-420 M-349 M-513 M
PurchaseOfPPE-769000.0-3 M-1 M-2 M-368000.0-1 M-2 M-552000.0-679000.0-383000.0
Revenue per share2 M13 M11 M2 M2 M2 M1 M1 M2 M2 M
Sale of short term investments90 M169 M157 M140 M198 M327 M307 M344 M400 M602 M
SaleOfInvestment90 M169 M157 M140 M198 M327 M307 M344 M400 M602 M
StockBasedCompensation9 M12 M9 M10 M12 M13 M13 M15 M16 M14 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University